Dr. Patrick W. Linson, MD

Dr. Linson practices at Scripps Clinic in Vista, California.

Dr. Linson's NPI, 1184618175, was assigned on September 6, 2005. Dr. Linson graduated from Harvard Medical School in 1997. Dr. Linson holds California license A83054.

Dr. Linson's primary practice is Scripps Clinic, at 916 Sycamore Ave Suite 100 Suite 100, Vista, CA 92081-7815. The practice phone is (760) 599-9545.

Dr. Linson's primary practice is Scripps Clinic in Vista, California. Dr. Linson is also affiliated with Scripps Green Hospital. The medical group on file is Scripps Clinic Medical Group. Dmand AI also links Dr. Linson to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Linson practices, 3 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Linson's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Linson is board certified in radiation oncology by the American Board of Radiology. Dr. Linson is licensed in California.

Dmand AI lists bone cancer radiation, brain cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Linson treats.

CMS data shows 7,701 Medicare services from Dr. Linson across 31 procedure codes in 2024, for 473 Medicare patients. Medicare paid $2,012,406 for them. Every service was in an office.

CMS counts 473 Medicare patients who saw Dr. Linson in 2024. The largest group is 75 to 84, with 218 patients. 75% of them have cancer, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.55, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Linson's median patient age at 71, with 28% women.

In 2024, Dr. Linson wrote 428 Medicare Part D claims for 147 patients. 99% of them were for generic drugs. CMS names the drug for 347 of them, across 6 drugs with 11 or more claims each, at $7,728 in total drug cost. In 2023, CMS named 270 claims across 4 drugs.

Dr. Linson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Linson as offering telehealth.

Dmand AI links 3 papers to Dr. Linson, published from 2018 to 2019. The most frequent topics are Prostate-Specific Antigen, Prostatic Neoplasms and Prostatectomy. Dr. Linson's most frequent co-authors are Mitchell S. Anscher, MD, Mark Emerson Augspurger, MD and Brian Francis Chapin, MD.

Dmand AI links Dr. Linson to 1 clinical trial.

CMS Open Payments shows 58 general payments to Dr. Linson from 27 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Brainlab, Inc. paid the most, $279.

Dmand AI lists 2 awards for Dr. Linson, most recently CMS Stage 1 EHR in 2013.

Dr. Linson graduated from Harvard Medical School in 1997.

Dr. Linson is in network with 4 carriers, including Aetna, United Healthcare and Blue Cross and Blue Shield of Kansas City. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.